ITC Hotels, now a separate debt-free entity, aims for accelerated growth with its six brands. ITC Hotels plans to increase its room capacity to over 18,000 rooms across 200 hotels by 2030 through an asset-right strategy. Managing Director Anil Chadha highlighted the focus on upscale and economy segments, and the continued importance of food and beverage in their revenue generation.
Related news
JSW MG Motor India reported a 55% increase in sales in December 2024, reaching 7,516 units. This includes a record high in EV sales, with over 70% from new energy vehicles. The company credits its success to the launch of its joint venture and plans to introduce new products every six months, starting at the Bharat Mobility Global Expo 2025.
British telecom firm Vodafone has sold its 3% stake in Indus Towers for Rs 2,800 crore, allocating Rs 890 crore for lender debt clearance and utilizing the remaining to increase its shareholding in Vodafone Idea to 24.39%. The transaction also settles Vodafone's obligations to Indus completely.
Gold ETFs inflows dropped 47.22% to Rs 1,979 crore in February despite record-high gold prices, reflecting profit-taking and equity market opportunities. However, inflows still saw a 99% year-on-year increase. UTI Gold ETF led with 3.70% returns. Gold remains an essential portfolio diversifier amid global uncertainty, with AUM growing 7% to Rs 55,677 crore.
Gold prices hit an all-time high of Rs 89,450 per 10 grams in the national capital, driven by strong global trends and safe-haven demand due to cooler-than-expected US inflation data. Gold and silver also saw gains in the futures market. Traders are now focused on upcoming US economic data, which could influence further market trends.
Aragen Life Science, formerly GVK Biosciences, secures a $100 million investment from healthcare-focused private equity fund Quadria Capital. The investment will support Aragen’s strategic expansion and infrastructure development to meet growing demand for outsourcing services from US and Europe innovators. This move positions Aragen strongly in the pharmaceutical outsourcing market, enhancing its capabilities and accelerating program delivery.
The International Gemmological Institute (India) Ltd's IPO was subscribed 72% on its second day. Retail investors showed strong interest, while institutional investors lagged. The IPO aims to raise ₹4,225 crore, with a portion going towards acquiring IGI Belgium and IGI Netherlands. The offer closes December 17.
The Trump administration's decision to exempt tariffs on Indian pharma imports brings relief to a $9 billion-plus US export market, highlighting India's key role in providing affordable generic medicines. However, India's medical device sector faces a 26% reciprocal tariff, potentially impacting its growth and exports.
Vivo India and Dixon Technologies are forming a joint venture for contract manufacturing electronics, including smartphones. Dixon will hold a 51% stake. The partnership aims to boost local manufacturing and Vivo's presence in India, with the JV handling some of Vivo's OEM orders and potentially those of other brands.
Eli Lilly plans to turn India into a growth market by addressing its diabetes and obesity challenges with its new treatment, Mounjaro. CEO David Ricks is optimistic about India's growth potential and highlights the transformative power of innovative medicines alongside generics in managing public health.
Budget 2025 income tax: Recognizing the contributions of the middle class and with an objective to eventually phase out the old tax regime, various changes have been introduced in the new tax regime. The basic exemption limit has been increased from INR 3 lakhs to INR 4 lakhs.